Galapagos NV (GLPG)
USD 23.52
(2.08%)
USD 23.52
(2.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -62.2 Million EUR | 87.21% |
| 2022 | -486.21 Million EUR | 77.96% |
| 2021 | -2.2 Billion EUR | -4.78% |
| 2020 | -2.1 Billion EUR | -14.68% |
| 2019 | -1.83 Billion EUR | -42.26% |
| 2018 | -1.29 Billion EUR | -12.13% |
| 2017 | -1.15 Billion EUR | -18.29% |
| 2016 | -973.17 Million EUR | -186.06% |
| 2015 | -340.19 Million EUR | -81.4% |
| 2014 | -187.54 Million EUR | -32.93% |
| 2013 | -141.08 Million EUR | -49.71% |
| 2012 | -94.24 Million EUR | -197.49% |
| 2011 | -31.67 Million EUR | 19.09% |
| 2010 | -39.15 Million EUR | 14.71% |
| 2009 | -45.9 Million EUR | -79.23% |
| 2008 | -25.61 Million EUR | 42.99% |
| 2007 | -44.92 Million EUR | -2.69% |
| 2006 | -43.75 Million EUR | -85.26% |
| 2005 | -23.61 Million EUR | -129.87% |
| 2004 | -10.27 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -65.39 Million EUR | 58.4% |
| 2024 Q2 | -41.45 Million EUR | 36.61% |
| 2023 Q4 | -157.2 Million EUR | -8.25% |
| 2023 Q1 | -108.13 Million USD | 77.76% |
| 2023 Q3 | -145.22 Million EUR | -75.8% |
| 2023 Q2 | -82.6 Million EUR | 23.61% |
| 2023 FY | -62.2 Million EUR | 87.21% |
| 2022 Q3 | -652.83 Million EUR | 31.19% |
| 2022 Q4 | -486.21 Million EUR | 25.52% |
| 2022 FY | -486.21 Million EUR | 77.96% |
| 2022 Q1 | -1.22 Billion EUR | 44.3% |
| 2022 Q2 | -948.74 Million EUR | 22.8% |
| 2021 Q4 | -2.2 Billion EUR | 21.42% |
| 2021 FY | -2.2 Billion EUR | -4.78% |
| 2021 Q2 | -2.61 Billion EUR | -3.54% |
| 2021 Q3 | -2.8 Billion EUR | -7.39% |
| 2021 Q1 | -2.52 Billion EUR | -19.92% |
| 2020 Q3 | -2.05 Billion EUR | 12.65% |
| 2020 Q1 | -2.71 Billion EUR | -48.05% |
| 2020 FY | -2.1 Billion EUR | -14.68% |
| 2020 Q4 | -2.1 Billion EUR | -2.28% |
| 2020 Q2 | -2.35 Billion EUR | 13.3% |
| 2019 Q1 | -1.19 Billion EUR | 7.2% |
| 2019 Q4 | -1.83 Billion EUR | 67.06% |
| 2019 FY | -1.83 Billion EUR | -42.26% |
| 2019 Q2 | -1.12 Billion EUR | 6.31% |
| 2019 Q3 | -5.57 Billion EUR | -396.73% |
| 2018 Q1 | -1.1 Billion EUR | 3.74% |
| 2018 FY | -1.29 Billion EUR | -12.13% |
| 2018 Q4 | -1.29 Billion EUR | 3.93% |
| 2018 Q3 | -1.34 Billion EUR | -25.96% |
| 2018 Q2 | -1.06 Billion EUR | 3.74% |
| 2017 Q2 | -1.26 Billion EUR | -32.38% |
| 2017 FY | -1.15 Billion EUR | -18.29% |
| 2017 Q1 | -953.33 Million EUR | 2.04% |
| 2017 Q3 | -1.21 Billion EUR | 3.42% |
| 2017 Q4 | -1.15 Billion EUR | 5.55% |
| 2016 Q2 | -960.39 Million EUR | 1.82% |
| 2016 Q4 | -973.17 Million EUR | -4.56% |
| 2016 FY | -973.17 Million EUR | -186.06% |
| 2016 Q3 | -930.73 Million EUR | 3.09% |
| 2016 Q1 | -978.23 Million EUR | -187.55% |
| 2015 Q1 | 187.71 Million EUR | 200.09% |
| 2015 Q4 | -340.19 Million EUR | 7.16% |
| 2015 Q3 | -366.41 Million EUR | 7.78% |
| 2015 Q2 | -397.33 Million EUR | -311.67% |
| 2015 FY | -340.19 Million EUR | -81.4% |
| 2014 Q4 | -187.54 Million EUR | 0.0% |
| 2014 FY | -187.54 Million EUR | -32.93% |
| 2014 Q2 | -231.27 Million EUR | -4.81% |
| 2014 Q1 | -220.66 Million EUR | -56.4% |
| 2013 Q1 | -136.42 Million EUR | -44.76% |
| 2013 Q4 | -141.08 Million EUR | -2.23% |
| 2013 FY | -141.08 Million EUR | -49.71% |
| 2013 Q2 | -136.18 Million EUR | 0.18% |
| 2013 Q3 | -138 Million EUR | -1.34% |
| 2012 Q3 | -94.64 Million EUR | 22.38% |
| 2012 Q4 | -94.24 Million EUR | 0.43% |
| 2012 Q2 | -121.93 Million EUR | 0.0% |
| 2012 FY | -94.24 Million EUR | -197.49% |
| 2011 Q2 | -48.68 Million EUR | 0.0% |
| 2011 Q4 | -31.67 Million EUR | 0.0% |
| 2011 FY | -31.67 Million EUR | 19.09% |
| 2010 Q2 | -25.89 Million EUR | 0.0% |
| 2010 FY | -39.15 Million EUR | 14.71% |
| 2010 Q4 | -39.15 Million EUR | 0.0% |
| 2009 FY | -45.9 Million EUR | -79.23% |
| 2009 Q2 | -16.99 Million EUR | 0.0% |
| 2009 Q4 | -45.9 Million EUR | 0.0% |
| 2008 Q4 | -25.61 Million EUR | 0.0% |
| 2008 FY | -25.61 Million EUR | 42.99% |
| 2007 FY | -44.92 Million EUR | -2.69% |
| 2006 FY | -43.75 Million EUR | -85.26% |
| 2005 FY | -23.61 Million EUR | -129.87% |
| 2004 FY | -10.27 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 61.25 Million USD | 201.551% |
| Jaguar Health, Inc. | 29.39 Million USD | 311.653% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 80.358% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -348.954% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 103.327% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -270.522% |
| ContextLogic Inc. | -232 Million USD | 73.187% |
| MiMedx Group, Inc. | -33.9 Million USD | -83.496% |
| MEI Pharma, Inc. | -3.7 Million USD | -1579.001% |
| AlloVir, Inc. | -62.69 Million USD | 0.774% |
| Novavax, Inc. | -298.29 Million USD | 79.146% |
| Aptorum Group Limited | 1.35 Million USD | 4684.001% |
| Ardelyx, Inc. | 34.51 Million USD | 280.247% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 1553.435% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1002.257% |
| Vaxcyte, Inc. | -368.22 Million USD | 83.106% |
| Precigen, Inc. | -481 Thousand USD | -12832.848% |
| Pharming Group N.V. | 109.8 Million USD | 156.653% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 74.333% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -257.594% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 323.823% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 64.5% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -2584.777% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -235.894% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -235.894% |
| Bicycle Therapeutics plc | -481.46 Million USD | 87.08% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -776.155% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -961.553% |
| Acelyrin, Inc. | -216.9 Million USD | 71.32% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -3508.295% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -814.405% |
| Senti Biosciences, Inc. | 1.74 Million USD | 3675.115% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 66.303% |
| AbCellera Biologics Inc. | -55.94 Million USD | -11.203% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -926.179% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 272.018% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 10005.573% |
| Chimerix, Inc. | -25.51 Million USD | -143.786% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 46.853% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 597.218% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 992.743% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 569.877% |
| Elevation Oncology, Inc. | -19.11 Million USD | -225.384% |
| Alkermes plc | -166.73 Million USD | 62.692% |
| Fortress Biotech, Inc. | 7.66 Million USD | 911.572% |
| Fortress Biotech, Inc. | 7.66 Million USD | 911.572% |
| Agenus Inc. | 274.13 Million USD | 122.692% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 43.723% |
| Dyadic International, Inc. | -6.37 Million USD | -875.322% |
| ImmuCell Corporation | 10.99 Million USD | 666.004% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -290.429% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 59.644% |
| Lantern Pharma Inc. | -21.7 Million USD | -186.625% |
| Immix Biopharma, Inc. | -17.5 Million USD | -255.27% |
| Incyte Corporation | -3.17 Billion USD | 98.041% |
| IO Biotech, Inc. | -140.69 Million USD | 55.787% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1265.58% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -628.148% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 611.433% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 19.682% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1167.203% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 51.82% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 460.036% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 156.108% |
| NextCure, Inc. | -6.47 Million USD | -860.429% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -23.18% |
| Onconetix, Inc. | 5.33 Million USD | 1266.796% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -875.184% |
| Opthea Limited | 28.15 Million USD | 320.926% |
| PDS Biotechnology Corporation | -32.7 Million USD | -90.184% |
| PureTech Health plc | -167.19 Million USD | 62.794% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 710.172% |
| Seer, Inc. | -4.24 Million USD | -1367.146% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1008.806% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 541.78% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 62451.031% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -104.225% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 63.023% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 138.461% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -11.855% |
| ChromaDex Corporation | -24.04 Million USD | -158.678% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -718.944% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -162.732% |
| CRISPR Therapeutics AG | -150.84 Million USD | 58.761% |
| Precision BioSciences, Inc. | -85.41 Million USD | 27.167% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 200.877% |
| Innoviva, Inc. | 255.56 Million USD | 124.341% |
| Summit Therapeutics Inc. | 34.67 Million USD | 279.405% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -158.797% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -11.354% |
| ESSA Pharma Inc. | -33.62 Million USD | -85.021% |
| GlycoMimetics, Inc. | -40.98 Million USD | -51.782% |
| GT Biopharma, Inc. | -1.02 Million USD | -5992.752% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 8.226% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 53.604% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -115.458% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -82474.933% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -101.565% |
| Aptose Biosciences Inc. | -8.19 Million USD | -659.098% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -1888.068% |
| Soligenix, Inc. | -4.95 Million USD | -1156.302% |
| Century Therapeutics, Inc. | 847 Thousand USD | 7444.392% |
| Kura Oncology, Inc. | -20.11 Million USD | -209.211% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -51.999% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -640.736% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 3514.787% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -1845.793% |
| Autolus Therapeutics plc | -186.59 Million USD | 66.663% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -26.17% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 77.444% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 281.531% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 137.846% |
| GRI Bio, Inc. | -1.79 Million USD | -3367.503% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -592.493% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -87.049% |
| IGM Biosciences, Inc. | -72.6 Million USD | 14.323% |
| INmune Bio, Inc. | -25.41 Million USD | -144.803% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 141.21% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -22.796% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -282.827% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -2056.277% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 263.638% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -51.043% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 295.098% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 116.459% |
| Verastem, Inc. | -37.27 Million USD | -66.873% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -585.628% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -19.947% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -311.014% |
| Histogen Inc. | -7.48 Million USD | -730.867% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -187.904% |
| Surrozen, Inc. | -32.66 Million USD | -90.445% |
| Organovo Holdings, Inc. | -1.5 Million USD | -4027.87% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1379.89% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 428.092% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 2477.943% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 1596.8% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -642.225% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -43.196% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -326.752% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 80.363% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -8515.212% |
| Apollomics, Inc. | -27.39 Million USD | -127.074% |
| Amarin Corporation plc | -191.04 Million USD | 67.438% |
| Mesoblast Limited | 55.96 Million USD | 211.157% |
| Turnstone Biologics Corp. | -14.58 Million USD | -326.543% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -145.955% |
| Synaptogenix, Inc. | -28.66 Million USD | -117.04% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -6546.047% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 227.651% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -7115.844% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -756.129% |
| Exelixis, Inc. | -73.05 Million USD | 14.843% |
| Better Therapeutics, Inc. | -860 Thousand USD | -7133.372% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -159.056% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 74.228% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 8551.28% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -736.325% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 5060.686% |
| Gritstone bio, Inc. | 39.49 Million USD | 257.526% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 26.033% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -2263.362% |
| Avid Bioservices, Inc. | 169.72 Million USD | 136.651% |
| Insmed Incorporated | 721.62 Million USD | 108.62% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -580.489% |
| MediWound Ltd. | -5.32 Million USD | -1068.865% |
| OmniAb, Inc. | 9.2 Million USD | 775.943% |
| Alector, Inc. | -35.63 Million USD | -74.557% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 172.358% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1162.317% |
| Zai Lab Limited | -775 Million USD | 91.973% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 118.266% |
| Aura Biosciences, Inc. | -21.52 Million USD | -188.999% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 24.579% |
| Immunic, Inc. | -45.34 Million USD | -37.201% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 67.804% |
| Veracyte, Inc. | -203.82 Million USD | 69.48% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 109.746% |
| FibroGen, Inc. | 56.76 Million USD | 209.583% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 798.563% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -2100.396% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -2904.664% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 101.355% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -1761.928% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 62.518% |
| TG Therapeutics, Inc. | 17.86 Million USD | 448.264% |
| Galecto, Inc. | -21.21 Million USD | -193.208% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -161.539% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 103.964% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -154.197% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -440.601% |
| XBiotech Inc. | -200.02 Million USD | 68.9% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 26.033% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 1473.83% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -76.409% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 19.44% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1193.077% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 63.497% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 32.657% |
| Vaxxinity, Inc. | 10.13 Million USD | 713.966% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 108.449% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -477.727% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 5.684% |
| NexImmune, Inc. | -3.13 Million USD | -1885.134% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -1701.706% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -311.655% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -129.546% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -593.033% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -49835.38% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -53.325% |
| Ainos, Inc. | 4.07 Million USD | 1625.456% |
| Pluri Inc. | 22.82 Million USD | 372.491% |
| Prothena Corporation plc | -608.34 Million USD | 89.774% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 47.618% |
| Celularity Inc. | 65.19 Million USD | 195.424% |
| Rallybio Corporation | -24.1 Million USD | -158.099% |
| Cue Biopharma, Inc. | -33.81 Million USD | -83.941% |
| MeiraGTx Holdings plc | -40.3 Million USD | -54.352% |
| Omeros Corporation | 331.17 Million USD | 118.784% |
| Humacyte, Inc. | -22.48 Million USD | -176.648% |
| Immunocore Holdings plc | -358.59 Million USD | 82.653% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -153.131% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -101.311% |
| Blueprint Medicines Corporation | 702.83 Million USD | 108.851% |
| CalciMedica, Inc. | -5.53 Million USD | -1024.901% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 66.95% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -509.037% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -55.374% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -87.072% |
| Pulmatrix, Inc. | -10.41 Million USD | -497.168% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -940.773% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -63.093% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 44.16% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -3.775% |
| Cytokinetics, Incorporated | 642.37 Million USD | 109.684% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -968.298% |
| Nutriband Inc. | -251.65 Thousand USD | -24618.963% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -82.324% |
| Vor Biopharma Inc. | 4.3 Million USD | 1546.674% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.969% |
| Evogene Ltd. | -19.63 Million USD | -216.833% |
| ProKidney Corp. | -56.23 Million USD | -10.618% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -27.809% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -573.441% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 104.561% |
| CorMedix Inc. | -43.05 Million USD | -44.491% |
| BioLineRx Ltd. | 7.33 Million USD | 947.969% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -126.496% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 234.802% |
| Atai Life Sciences N.V. | -28.55 Million USD | -117.827% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 2888.89% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -172.646% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 450.758% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 17.139% |
| MediciNova, Inc. | -50.78 Million USD | -22.494% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 21.062% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -276437.008% |
| GeoVax Labs, Inc. | -6.45 Million USD | -864.063% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 68.869% |
| Biomea Fusion, Inc. | -166.57 Million USD | 62.654% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 65.243% |
| Mereo BioPharma Group plc | -51.46 Million USD | -20.863% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 34.411% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 78.824% |
| Absci Corporation | -72.59 Million USD | 14.313% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1462.396% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 73.465% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 33.971% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 34.995% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -59.207% |
| Allakos Inc. | -24.97 Million USD | -149.077% |
| Imunon, Inc. | -4.21 Million USD | -1376.25% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -321.971% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 54.057% |
| BioAtla, Inc. | -109.01 Million USD | 42.935% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 8551.28% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -6524.814% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 619.865% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -193.388% |
| XOMA Corporation | -29 Million USD | -114.507% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -275.646% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -589.962% |
| aTyr Pharma, Inc. | -7.44 Million USD | -735.105% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 50.089% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 70.116% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 23.933% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 32.94% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -7140.242% |
| Akari Therapeutics, Plc | -3.84 Million USD | -1517.867% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 3933.1% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 104.505% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -5135.684% |
| UroGen Pharma Ltd. | 4.39 Million USD | 1516.693% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 154.817% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 86544.234% |
| Orgenesis Inc. | 21.78 Million USD | 385.563% |
| Entera Bio Ltd. | -10.62 Million USD | -485.257% |
| GH Research PLC | -78.07 Million USD | 20.326% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -179.105% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -133.343% |
| Xencor, Inc. | 29.64 Million USD | 309.847% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -3058.017% |
| Replimune Group, Inc. | 1.41 Million USD | 4505.595% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -25300.15% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 50.792% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -5135.684% |
| Portage Biotech Inc. | -4.98 Million USD | -1148.886% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -276437.008% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 5.921% |
| OncoCyte Corporation | -6.56 Million USD | -847.844% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 7031.814% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1265.493% |
| Purple Biotech Ltd. | -14.13 Million USD | -339.999% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -161.858% |
| scPharmaceuticals Inc. | -6.54 Million USD | -850.451% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -272.672% |
| HilleVax, Inc. | -165.48 Million USD | 62.409% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -2351.024% |
| Tharimmune, Inc. | -10.93 Million USD | -468.861% |
| Genprex, Inc. | -6.73 Million USD | -823.277% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 83.133% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 29.678% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -4340.186% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -1775.43% |
| OKYO Pharma Limited | -826.84 Thousand USD | -7423.39% |
| Savara Inc. | 153 Thousand USD | 40758.17% |
| Curis, Inc. | -23.88 Million USD | -160.422% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1106.05% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -7916.242% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -902.046% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 5349.536% |
| BeiGene, Ltd. | -2.25 Billion USD | 97.239% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 604.17% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 89.772% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 66.481% |
| Erasca, Inc. | -37.21 Million USD | -67.151% |
| bluebird bio, Inc. | 108.57 Million USD | 157.296% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -4730.137% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 116.424% |
| DBV Technologies S.A. | -126.98 Million USD | 51.013% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -4730.137% |
| Moderna, Inc. | -2.9 Billion USD | 97.86% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -500.918% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -472.387% |
| Molecular Templates, Inc. | 707 Thousand USD | 8898.727% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -98.295% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 117.947% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 24.195% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 32.185% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -92.758% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -80.961% |
| MacroGenics, Inc. | -66.98 Million USD | 7.133% |
| RenovoRx, Inc. | -1.17 Million USD | -5203.24% |
| Adicet Bio, Inc. | -138.78 Million USD | 55.178% |
| Prime Medicine, Inc. | -27.94 Million USD | -122.637% |
| Aditxt, Inc. | 18.12 Million USD | 443.289% |
| Adagene Inc. | -87.62 Million USD | 29.01% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1393.412% |
| Quantum-Si incorporated | -118.55 Million USD | 47.53% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 272.773% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -732.291% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -28.238% |
| SciSparc Ltd. | -2.06 Million USD | -2912.446% |
| Vericel Corporation | 1.27 Million USD | 4971.339% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -418.75% |
| Minerva Neurosciences, Inc. | 41 Million USD | 251.709% |
| Generation Bio Co. | 31.44 Million USD | 297.809% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 64.527% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -101.167% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 153.354% |
| Invivyd, Inc. | -198.47 Million USD | 68.658% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 31.088% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -2494.457% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 12.125% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -811.458% |
| 2seventy bio, Inc. | 181.71 Million USD | 134.233% |
| ADMA Biologics, Inc. | 90.06 Million USD | 169.068% |
| Clene Inc. | 3.34 Million USD | 1962.485% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -584.895% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -189.187% |
| GeoVax Labs, Inc. | -6.45 Million USD | -864.063% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 81.923% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -139.261% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 135.013% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -1420.371% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 1343.643% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1094.222% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 52.26% |
| Evaxion Biotech A/S | 5.28 Million USD | 1276.638% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 44.738% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 52.612% |
| Trevena, Inc. | 2.25 Million USD | 2854.96% |
| Surrozen, Inc. | -32.66 Million USD | -90.445% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -20.767% |
| Cingulate Inc. | 3.08 Million USD | 2117.95% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -2018.046% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 965.549% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -569.524% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 21.578% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 52.677% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 41.059% |
| Clearmind Medicine Inc. | -3.94 Million USD | -1477.802% |
| Kronos Bio, Inc. | -36.05 Million USD | -72.538% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 761.144% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 4366.226% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -14.655% |
| Statera Biopharma, Inc. | 14.41 Million USD | 531.501% |
| ImmunityBio, Inc. | 618.22 Million USD | 110.062% |
| Korro Bio, Inc. | -132.94 Million USD | 53.208% |
| Kineta, Inc. | -4.54 Million USD | -1269.896% |
| BioVie Inc. | -17.73 Million USD | -250.811% |
| Codexis, Inc. | -43.27 Million USD | -43.761% |
| Celularity Inc. | 65.19 Million USD | 195.424% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -1862.985% |
| Celcuity Inc. | 6.78 Million USD | 1017.033% |
| Virax Biolabs Group Limited | -3.36 Million USD | -1748.679% |
| Cibus, Inc. | -8.07 Million USD | -670.079% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -1370.962% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 1461.204% |
| IN8bio, Inc. | -16.38 Million USD | -279.566% |
| Kodiak Sciences Inc. | -103.87 Million USD | 40.114% |
| Annexon, Inc. | -193.75 Million USD | 67.894% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 172897.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -255.489% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -1670.766% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 105.9% |
| Eyenovia, Inc. | 1.25 Million USD | 5042.155% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 331.21% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1818.193% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -87.106% |
| Arcellx, Inc. | -296.95 Million USD | 79.052% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -218.912% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -5.659% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -200.125% |
| Moolec Science SA | 117.61 Thousand USD | 52989.913% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -62.002% |
| Geron Corporation | 14.76 Million USD | 521.428% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -64.057% |
| Royalty Pharma plc | 5.65 Billion USD | 101.099% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 56.013% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -790.016% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1059.96% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 55.797% |
| Humacyte, Inc. | -22.48 Million USD | -176.648% |
| Structure Therapeutics Inc. | -124.33 Million USD | 49.97% |
| 89bio, Inc. | -289.05 Million USD | 78.479% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -146.442% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -3388.895% |
| Genelux Corporation | -6.89 Million USD | -801.681% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -100.287% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 174.411% |
| Notable Labs, Ltd. | -9.77 Million USD | -536.324% |
| Liquidia Corporation | -80.17 Million USD | 22.412% |
| Mustang Bio, Inc. | -3.73 Million USD | -1565.07% |
| Immunovant, Inc. | -635.22 Million USD | 90.207% |
| Quantum-Si incorporated | -118.55 Million USD | 47.53% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -254.173% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -1401.497% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 874.972% |
| Acasti Pharma Inc. | -23 Million USD | -170.406% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -1747.424% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -282.827% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 54.837% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -1896.142% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -179.808% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -235.005% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 63.252% |
| PepGen Inc. | -60.67 Million USD | -2.533% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -170.748% |
| United Therapeutics Corporation | -507.7 Million USD | 87.747% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -225.248% |
| Solid Biosciences Inc. | -47.75 Million USD | -30.276% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -7115.844% |
| Immuneering Corporation | -54.94 Million USD | -13.221% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1379.89% |
| Silo Pharma, Inc. | -3.52 Million USD | -1665.084% |
| Belite Bio, Inc | -87.27 Million USD | 28.72% |
| XOMA Corporation | -29 Million USD | -114.507% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 12.009% |
| Bionomics Limited | 227 Million USD | 127.403% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 46.503% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2355.863% |
| uniQure N.V. | -102.95 Million USD | 39.576% |
| Cassava Sciences, Inc. | -121.13 Million USD | 48.647% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1393.412% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 251.906% |
| Forte Biosciences, Inc. | -11.96 Million USD | -420.082% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -1910.439% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 58785.849% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1818.193% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 798.563% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -738.821% |
| Altimmune, Inc. | -134.48 Million USD | 53.745% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 131.407% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2355.863% |
| Compugen Ltd. | -12.9 Million USD | -382.075% |
| Peak Bio, Inc. | 10.34 Million USD | 701.606% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -21881.272% |
| Benitec Biopharma Inc. | -50.58 Million USD | -22.982% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 40.379% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 416.656% |
| Zura Bio Limited | -99.8 Million USD | 37.672% |
| PolyPid Ltd. | 6.17 Million USD | 1108.217% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 183.927% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 416.656% |
| Instil Bio, Inc. | 75.35 Million USD | 182.549% |
| argenx SE | -2.02 Billion USD | 96.934% |
| Immunome, Inc. | -97.02 Million USD | 35.888% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -176.537% |
| Verona Pharma plc | -220.44 Million USD | 71.781% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 13.292% |
| Shattuck Labs, Inc. | -121.42 Million USD | 48.769% |
| CervoMed Inc. | -7.79 Million USD | -698.258% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 66.465% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -1322.525% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 52.78% |
| Moolec Science SA | 117.61 Thousand USD | 52989.913% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -2618.865% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 491.279% |
| AnaptysBio, Inc. | -18.15 Million USD | -242.719% |
| Design Therapeutics, Inc. | -18.15 Million USD | -242.738% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 11.614% |
| NeurAxis, Inc. | 145.7 Thousand USD | 42795.264% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 653.837% |
| Lumos Pharma, Inc. | -28.49 Million USD | -118.324% |
| Achilles Therapeutics plc | -126.92 Million USD | 50.989% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 13.292% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -9386.679% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -199.449% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 4366.226% |
| Nutriband Inc. | -251.65 Thousand USD | -24618.963% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -372.303% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -736.116% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 118.286% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 362.09% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 86.098% |
| Palisade Bio, Inc. | -12.06 Million USD | -415.684% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 55.665% |
| Beam Therapeutics Inc. | -262.72 Million USD | 76.322% |
| Neurogene Inc. | -131.95 Million USD | 52.857% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 385.144% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1174.734% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 83.508% |
| Sesen Bio, Inc. | -112.55 Million USD | 44.731% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 37.706% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -2549.595% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -59.399% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 25.306% |
| Athira Pharma, Inc. | -88.99 Million USD | 30.104% |
| Vaccinex, Inc. | -1.28 Million USD | -4729.736% |
| HCW Biologics Inc. | 2.85 Million USD | 2277.601% |
| XOMA Corporation | -29 Million USD | -114.507% |
| Nektar Therapeutics | 210.24 Million USD | 129.589% |
| Arvinas, Inc. | -313.8 Million USD | 80.176% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 3933.1% |
| Merus N.V. | -192.88 Million USD | 67.749% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 203.704% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -796.613% |
| Rezolute, Inc. | -68.16 Million USD | 8.745% |
| Clene Inc. | 3.34 Million USD | 1962.485% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -371.73% |
| BeyondSpring Inc. | -13.75 Million USD | -352.25% |
| Synlogic, Inc. | -6.68 Million USD | -830.546% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 5585.626% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -635.742% |
| Peak Bio, Inc. | 10.34 Million USD | 701.606% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 24.524% |
| Krystal Biotech, Inc. | -350.23 Million USD | 82.238% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 150.116% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 63.19% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -1870.357% |
| MannKind Corporation | 143.89 Million USD | 143.23% |
| Ikena Oncology, Inc. | -109.15 Million USD | 43.011% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -721.648% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -87.937% |
| Gossamer Bio, Inc. | 180.35 Million USD | 134.491% |
| CohBar, Inc. | -5.93 Million USD | -948.893% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -109.113% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1462.396% |
| Legend Biotech Corporation | -949.39 Million USD | 93.448% |
| Mural Oncology plc | -255.84 Million USD | 75.685% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 293.099% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1220.563% |
| Disc Medicine, Inc. | -358.28 Million USD | 82.637% |
| Champions Oncology, Inc. | 4.81 Million USD | 1392.747% |
| REGENXBIO Inc. | 54.76 Million USD | 213.583% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -23033.277% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 58.81% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -590.268% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 22.899% |
| Vaxart, Inc. | -8.24 Million USD | -654.848% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -23.968% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 51.082% |
| Cellectis S.A. | -43.85 Million USD | -41.847% |
| Longeveron Inc. | -2.9 Million USD | -2039.168% |
| Repare Therapeutics Inc. | -107.85 Million USD | 42.325% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 106.424% |
| Inozyme Pharma, Inc. | 12 Million USD | 618.219% |
| Revolution Medicines, Inc. | -608.2 Million USD | 89.772% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -4957.48% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 76.536% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 58.549% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -297.565% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -8306.351% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.35% |
| Denali Therapeutics Inc. | -74.86 Million USD | 16.908% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -418.75% |
| Veru Inc. | 4.77 Million USD | 1401.41% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -453.148% |
| Cingulate Inc. | 3.08 Million USD | 2117.95% |
| Passage Bio, Inc. | 4.58 Million USD | 1456.75% |
| Context Therapeutics Inc. | -14.44 Million USD | -330.503% |
| Exicure, Inc. | 5.84 Million USD | 1163.549% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 72.998% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -57.207% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 496.45% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -5.756% |
| Nuvalent, Inc. | -335.38 Million USD | 81.452% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 3686.78% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 16.48% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -599.741% |
| OmniAb, Inc. | 9.2 Million USD | 775.943% |
| Anew Medical, Inc. | 1.43 Million USD | 4442.654% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 479.733% |
| Lipocine Inc. | -4.75 Million USD | -1208.356% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 43.36% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 508.424% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -22.796% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 349.908% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -825.562% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 5.499% |
| Ocugen, Inc. | -32.52 Million USD | -91.283% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 27.307% |
| Q32 Bio Inc. | -37.94 Million USD | -63.927% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -9805.573% |
| Alumis Inc. Common Stock | -13.52 Million USD | -359.805% |
| Equillium, Inc. | -22.39 Million USD | -177.809% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -143.3% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -90.662% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -24992.068% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 146.409% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 2045.184% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 19040.084% |
| Dominari Holdings Inc. | 195 Thousand USD | 32001.026% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1081.091% |
| vTv Therapeutics Inc. | -8.91 Million USD | -597.623% |
| Bio-Techne Corporation | 267.74 Million USD | 123.234% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -283.781% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 47.324% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -640.295% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -391.716% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 74.622% |
| Nkarta, Inc. | 57.29 Million USD | 208.566% |
| BioCardia, Inc. | 212 Thousand USD | 29442.925% |
| Iterum Therapeutics plc | 13.43 Million USD | 562.919% |